Gland Pharma Limited (GLAND.BO)
INR 1586.0
(0.3%)
INR 1586.0
(0.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.9 Billion INR | 11.31% |
| 2022 | 8.88 Billion INR | -36.72% |
| 2021 | 14.03 Billion INR | 19.07% |
| 2020 | 11.78 Billion INR | 46.3% |
| 2019 | 8.05 Billion INR | 40.48% |
| 2018 | 5.73 Billion INR | 37.29% |
| 2017 | 4.17 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.72 Billion INR | -35.19% |
| 2024 Q2 | 2.03 Billion INR | 17.86% |
| 2023 Q2 | 2.42 Billion INR | 6.18% |
| 2023 FY | 9.88 Billion INR | 11.31% |
| 2023 Q4 | 2.66 Billion INR | -7.76% |
| 2023 Q3 | 2.88 Billion INR | 18.81% |
| 2023 Q1 | 2.28 Billion INR | 74.7% |
| 2022 Q4 | 1.3 Billion INR | -48.06% |
| 2022 Q3 | 2.51 Billion INR | -3.16% |
| 2022 Q2 | 2.6 Billion INR | 10.71% |
| 2022 FY | 8.88 Billion INR | -36.72% |
| 2022 Q1 | 2.35 Billion INR | -25.93% |
| 2021 Q3 | 3.21 Billion INR | -8.39% |
| 2021 Q1 | 4.11 Billion INR | 35.76% |
| 2021 Q2 | 3.5 Billion INR | -14.72% |
| 2021 FY | 14.03 Billion INR | 19.07% |
| 2021 Q4 | 3.17 Billion INR | -1.18% |
| 2020 Q1 | 4.2 Billion INR | 61.07% |
| 2020 Q4 | 3.02 Billion INR | 10.33% |
| 2020 Q3 | 2.74 Billion INR | -6.47% |
| 2020 Q2 | 2.93 Billion INR | -30.22% |
| 2020 FY | 11.78 Billion INR | 46.3% |
| 2019 Q3 | 2.12 Billion INR | 0.0% |
| 2019 Q4 | 2.61 Billion INR | 22.66% |
| 2019 Q1 | 2.56 Billion INR | 0.0% |
| 2019 FY | 8.05 Billion INR | 40.48% |
| 2018 FY | 5.73 Billion INR | 37.29% |
| 2017 FY | 4.17 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott India Limited | 13.79 Billion INR | 28.176% |
| Cipla Limited | 105.7 Billion INR | 90.628% |
| GlaxoSmithKline Pharmaceuticals Limited | 13.6 Billion INR | 27.163% |
| Kopran Limited | 615.26 Million INR | -1510.258% |
| Marksans Pharma Limited | 7.79 Billion INR | -27.154% |
| NGL Fine-Chem Limited | 416.27 Million INR | -2280.022% |
| Pfizer Limited | 9.61 Billion INR | -3.076% |
| Sanofi India Limited | 7.79 Billion INR | -27.033% |
| SMS Pharmaceuticals Limited | 833.64 Million INR | -1088.438% |